| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 14.11.2005 (6740
dage). |
Ingen historik.
| Branche | | Sundhedsvæsen i øvrigt i.a.n (869090). |
| Sidst opdateret den 24.12.2007 og
angivet som gældende fra 01.01.2008 (5962
dage). |
| Historik | Start | Stop |
|---|
| Sundhedsvæsen i øvrigt i.a.n (869090) | 01.01.2008 | |
| Lægelaboratorier (851450) | 01.10.2006 | 31.12.2007 |
| Uoplyst (980000) | 14.11.2005 | 30.09.2006 |
| Revisionfravalgt | | false. |
| Sidst opdateret den 11.03.2015 og
angivet som gældende fra 14.11.2005 (6740
dage). |
Ingen historik.
| Historik | Start | Stop |
|---|
| fiala@serendex.com | 12.01.2010 | 30.04.2012 |
| Virksomheden har ikke ændret Kontakt i sin
levetid. |
Ingen nuværende registrering.
| Historik | Start | Stop |
|---|
| 43583759 | 12.01.2010 | 30.04.2012 |
| Virksomheden har ikke ændret Telefon i sin
levetid. |
Ingen nuværende registrering.
| Navne | | PHARMAORIGIN ApS. |
| Sidst opdateret den 29.11.2005 og
angivet som gældende fra 23.11.2005 (6731
dage). |
| Historik | Start | Stop |
|---|
| PHARMAORIGIN ApS | 23.11.2005 | |
| ApS KBUS 17 NR. 4503 | 14.11.2005 | 22.11.2005 |
| Binavne | | PHARMAORIGIN.COM ApS. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 14.11.2005 (6740
dage). |
Ingen historik.
| Tegningsregel | | Selskabet tegnes af en direktør. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 21.06.2012 (4329
dage). |
| Fortolkning
(1 tegningsmulighed)
| | 1 direktør |
Ingen historik.
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:Grant Thornton Statsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:34209936
Beskrivelse af revisor:State Authorised Public Accountant
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):Basis for opinionWe conducted our audit in accordance with international standards on auditing andthe additional requirements applicable in Denmark. Our responsibilities under thosestandards and requirements are further described in the section ”Auditor´s responsibi-lities for the audit of the financial statements”. We are independent of the company inaccordance with international ethical requirements for auditors (IESBA’s Code of Ethics)and the additional requirements applicable in Denmark, and we have fulfilled our otherethical responsibilities in accordance with these requirements. We believe that the auditevidence we have obtained is sufficient and appropriate to provide a basis for our opini-on.
Konklusion (revision):OpinionWe have audited the financial statements of Pharmaorigin ApS for the financial year 1January to 31 December 2021, which comprise accounting policies, income statement,statement of financial position and notes. The financial statements have been preparedin accordance with the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the company’s assets,equity and liabilities, and financial position at 31 December 2021 and of the results ofthe company’s activities for the financial year 1 January to 31 December 2021 in accor-dance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on the management commentaryThe management is responsible for the management commentary. Our opinion on the financial statements døs not cover the management commentary,and we express no assurance opinion thereon. In connection with our audit of the financial statements, it is our responsibility is to readthe management commentary and to consider whether the management commentary ismaterially inconsistent with the financial statements or the evidence obtained during theaudit, or whether it otherwise appears to contain material misstatement. Furthermore, it is our responsibility to consider whether the management commentaryprovides the information required under the Danish Financial Statements Act. Based on the work we have performed, we believe that the management commentaryis consistent with the financial statements and that it has been prepared in accordancewith the provisions of the Danish Financial Statement Act. We did not discover any mate-rial misstatement in the management commentary.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration